Directory
>
Kam Sprott
Kam Sprott
Development Scientist | Deciphera Pharmaceuticals
Massachusetts, Boston, United States
Kam Sprott
Summary
Kam Sprott is an accomplished Executive Director in Translational Medicine with over 20 years of experience in the pharmaceutical industry, particularly in oncology and immuno-oncology. He has a proven track record in developing and implementing clinical biomarker strategies, leading both internal research teams and external Contract Research Organizations. His educational background includes a Ph.D. in Molecular Biosciences from the University of Kansas. Kam's role at Deciphera Pharmaceuticals showcases his leadership in advancing cancer therapies through innovative translational approaches. He has also held significant positions at notable companies like Verastem Oncology and Infinity Pharmaceuticals, contributing to product development and clinical research. His extensive experience positions him as a key player in the field of cancer research, with a focus on improving patient outcomes through technology and collaboration. Kam's passion for translational medicine drives his commitment to enhancing decision-making tools for physicians treating cancer patients.
Kam Sprott
Work Experience
Executive Director, Translational Medicine at
Deciphera Pharmaceuticals
January 2020 - Present
Kam Sprott
Education
University of Kansas, Ph.D., Molecular Biosciences
January 1996 - January 2001
Frequently Asked Questions about Kam Sprott
What is Kam Sprott email address?
Kam Sprott's primary email address is *******@deciphera.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kam Sprott work for?
Kam Sprott is a Development Scientist at Deciphera Pharmaceuticals.
Where Kam Sprott graduated from?
Kam Sprott holds a degree in null from University of Kansas.
How can I directly contact Kam Sprott?
To contact Kam Sprott directly, you can use the email address *******@deciphera.com. Complete contact information is available upon registration with Muraena.
Who is Kam Sprott?
Kam Sprott is an accomplished Executive Director in Translational Medicine with over 20 years of experience in the pharmaceutical industry, particularly in oncology and immuno-oncology. He has a proven track record in developing and implementing clinical biomarker strategies, leading both internal research teams and external Contract Research Organizations. His educational background includes a Ph.D. in Molecular Biosciences from the University of Kansas. Kam's role at Deciphera Pharmaceuticals showcases his leadership in advancing cancer therapies through innovative translational approaches. He has also held significant positions at notable companies like Verastem Oncology and Infinity Pharmaceuticals, contributing to product development and clinical research. His extensive experience positions him as a key player in the field of cancer research, with a focus on improving patient outcomes through technology and collaboration. Kam's passion for translational medicine drives his commitment to enhancing decision-making tools for physicians treating cancer patients.
Kam`s contact details
*******@deciphera.com
*******@verastem.com
********@sprottbio.com
Colleagues
Clinical Data Associate
Lab Supervisor
Assistant Professor in Biostatistics
Senior Clinical Oncology Specialist- Her2 Breast Cancer
Vice President, Chemical Development & Manufacturing
Interim at the Hospital Pharmacy
Various positions
Principal
Supervisor, Analytical R&D
Vice President, Late Clinical Development